Effect of nasturtium extract on oral cancer

Nilash, Amid B; Jahanbani, Jahanfar; Jolehar, Maryam

Effect of nasturtium extract on oral cancer

Authors

¹ General Dentist, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

² Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Abstract

Background: Considering the global prevalence of cancers and the complications of common cancer treatments, there is growing interest in using medicinal herbs to complement cancer treatments and reduce treatment's side effects. Therefore, we investigate the effect of the extract of Nasturtium on the viability of oral cancer cells.
Materials and Methods: In this experimental study, we prepared aqueous extract from Nasturtium leaves and human oral cancer cells (OCC-24) and normal fibroblast cells (HF2FF cell line) from a cell bank. Then the toxic effect of different concentrations of the extract on cell viability after 24–48 hours of exposure was investigated with the methylthiazol tetrazolium assay. Ultimately, the optical density was measured at 570 nm by an Elisa Reader. Analysis of inhibitory concentration 50 (IC50) was also performed. The data were analyzed by paired Student's t-test and one-way analysis of variance.
Results: Data showed that the extract had statistically significant anticancer effects in concentrations above 0.125 mg/ml for 24-hour exposure and in concentrations above 0.5 mg/ml for 48-hour exposure (p-value <0.05). Also, this extract had an adverse effect on the viability of normal cells; however, this effect occurred in high doses of the extract (p-value <0.05). Analysis of IC50 criteria indicates that with increasing time, a higher concentration of the extract is required to inhibit the viability of cancer cells.
Conclusion: Because of the results, this aqueous extract can be suggested as a potential therapeutic agent in oral cancer. The best concentration of the extract was found to be 1 mg/ml.

Keywords

References

1.	Kacher JE. Oral and maxillofacial pathology. Case of the month. Histoplasmosis. Tex Dent J 2013;130:198, 232.
2.	Hertrampf K, Pritzkuleit R, Baumann E, Wiltfang J, Wenz HJ, Waldmann A. Oral cancer awareness campaign in Northern Germany: First positive trends in incidence and tumor stages. J Cancer Res Clin Oncol 2020;146:2489-96.
3.	Prakash S, Radha, Kumar M, Kumari N, Thakur M, Rathour S, et al. Plant-based antioxidant extracts and compounds in the management of oral cancer. Antioxidants 2021;10:1358.
4.	Rajalakshmi PA, Agalyaa S. Docking analysis of phenethyl isothiocyanate (PEITC) from Nasturtium Officinale (Watercress), on 4-(Methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK), carcinogenic action in oral cancer. Int J Pharma Bio Sci 2010;1:B67-74.
5.	Chaudhary S, Hisham H, Mohamed D. A review on phytochemical and pharmacological potential of watercress plant. Asian J Pharm Clin Res 2018;11:102-7.
6.	Soundararajan P, Kim JS. Anti-carcinogenic glucosinolates in cruciferous vegetables and their antagonistic effects on prevention of cancers. Molecules 2018;23:1-21.
7.	Barba FJ, Nikmaram N, Roohinejad S, Khelfa A, Zhu Z, Koubaa M. Bioavailability of glucosinolates and their breakdown products: Impact of processing. Front Nutr 2016;3:24.
8.	Hecht SS, Chung FL, Richie JP Jr, Akerkar SA, Borukhova A, Skowronski L, et al. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol Biomarkers Prev 1995;4:877-84.
9.	Yeh YT, Yeh H, Su SH, Lin JS, Lee KJ, Shyu HW, Chen ZF, Huang SY, Su SJ. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations. Free Radic Biol Med 2014;74:1-13.
10.	Chen PY, Lin KC, Lin JP, Tang NY, Yang JS, Lu KW, et al. Phenethyl isothiocyanate (PEITC) inhibits the growth of human oral squamous carcinoma HSC-3 cells through G (0)/G (1) phase arrest and mitochondria-mediated apoptotic cell death. Evid Based Complement Alternat Med 2012;2012:718320.
11.	Kyriakou S, Tragkola V, Alghol H, Anestopoulos I, Amery T, Stewart K, et al. Evaluation of bioactive properties of lipophilic fractions of edible and non-edible parts of nasturtium officinale (watercress) in a model of human malignant melanoma cells. Pharmaceuticals 2022;15:1-21.
12.	Mitsiogianni M, Koutsidis G, Mavroudis N, Trafalis DT, Botaitis S, Franco R, et al. The role of isothiocyanates as cancer chemo-preventive, chemo-therapeutic and anti-melanoma agents. Antioxidants (Basel) 2019;8:1-35.
13.	Panahi Kokhdan E, Khodabandehloo H, Ghahremani H, Doustimotlagh AH. A narrative review on therapeutic potentials of watercress in human disorders. Evid Based Complement Altern Med 2021;2021:5516450.
14.	Ozen T. Investigation of antioxidant properties of Nasturtium officinale (watercress) leaf extracts. Acta Pol Pharm 2009;66:187-93.
15.	Khakrizi E, Bikhof Torbati M, Shaabanzadeh M. The study of anticancer effect of magnetic Chitosan-hydroxyurea nano drug on Hela. J Rafsanjan Univ Med Sci 2018;17:715-30.
16.	Fallah N, Ebrahimi S. The anti-cancer effect of watercress (Rorripa Nasturtium Aquaticum) extract on breast cancer cells. Zahedan J Res Med Sci 2016;18:e2725.
17.	Moradi R, Ebrahimi S, Taravati A, Asrardel F, Khorasani HR, Aghajanpour M, et al. Cytotoxic effects of the hydroalcoholic extract of rorippa nasturtium aquaticum on hela cell line. Int Biol Biomed J 2017;3:73-9.
18.	Sefidkon F, Torabi Sagvand B, Naderi M, Ghushegir SA. Comparision of anti-cancer effects of nanocapsules of nasturtium officinalis extract with methanolic extract and its fractions. Iranian Journal of Medicinal and Aromatic Plants (IJMAPR) 2013;29:35-50.
19.	Bikhof Torbati M, Ebrahimian M, Yousefi M, Shaabanzadeh M. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line. Artif Cells Nanomed Biotechnol 2017;45:568-73.
20.	Aggarwal M, Saxena R, Asif N, Sinclair E, Tan J, Cruz I, et al. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition. J Exp Clin Cancer Res 2019;38:307.
21.	Rose P, Faulkner K, Williamson G, Mithen R. 7-Methylsulfinylheptyl and 8-methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes. Carcinogenesis 2000;21:1983-8.
22.	Rapley J, Oshiro N, Ortiz-Vega S, Avruch J. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling. J Biol Chem 2011;286:38043-53.
23.	Yalçinkaya E, Özgüç S, Törer Y.O, Zeybek U. The importance of the medicinal plant Nasturtium Officinale L. in the anticancer activity research. J Sci Perspect 2019;3:159-64.
24.	De Souza DA, Costa PM, Ribeiro RIMA, Vidigal PVT, Pinto FCH. Daily intake of watercress causes inhibition of experimental Ehrlich tumor growth. J Bras Patol e Med Lab 2016;52:393-9.
25.	Sedaghattalab M, Razazan M, Sadeghi H, Doustimotlagh AM, Akbartabar Toori M, Abbasi Larki R, et al. Effects of nasturtium officinale extract on antioxidant and biochemical parameters in hemodialysis patients: A randomized double-blind clinical trial. Evid Based Complement Alternat Med 2021;2021:1632957.
26.	Gill CI, Haldar S, Boyd LA, Bennett R, Whiteford J, Butler M, et al. Watercress supplementation in diet reduces lymphocyte DNA damage and alters blood antioxidant status in healthy adults. Am J Clin Nutr 2007;85:504-10.
27.	Boyd LA, McCann MJ, Hashim Y, Bennett RN, Gill CIR, Rowland IR. Assessment of the antigenotoxic, anti-proliferative, and anti-metastatic potential of crude watercress extract in human colon cancer cells. Nutr Cancer 2006;55:232-41.

Advanced Biomedical Research